Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial

(2019) David R Matthews et al.   LANCET

VERIFY the role of initial combination therapy in patients with type 2 diabetes

(2019) Ofri Mosenzon et al.   LANCET

Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review

(2019) Dongzhe Hong et al.   PHARMACOECONOMICS

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020

(2019)   DIABETES CARE

2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2019) John B. Buse et al.   DIABETOLOGIA

The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (the Diabetes & Aging Study)

(2018) Neda Laiteerapong et al.   DIABETES CARE

Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2018) Melanie J. Davies et al.   DIABETOLOGIA

Beating type 2 diabetes into remission

(2017) Louise McCombie et al.   BMJ-British Medical Journal

Beating type 2 diabetes into remission

(2017) Louise McCombie et al.   BMJ-British Medical Journal

Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes

(2016) Avivit Cahn et al.   DIABETES CARE

Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System

(2016) Kevin M. Pantalone et al.   DIABETES CARE

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2015) Silvio E. Inzucchi et al.   DIABETOLOGIA

Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus

(2014) W.D. Strain et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Study to determine the durability of glycaemic control with early treatment with a vildagliptin-metformin combination regimen vs. standard-of-care metformin monotherapy-the VERIFY trial: a randomized double-blind trial

(2014) S. Del Prato et al.   DIABETIC MEDICINE

Vildagliptin, a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metformin

(2014) Thomas Forst et al.   EXPERT OPINION ON PHARMACOTHERAPY

Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes

(2013) R. A. DeFronzo et al.   DIABETES CARE

Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real-life worldwide observational study (EDGE)

(2013) C. Mathieu et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Clinical Pharmacokinetics and Pharmacodynamics of Vildagliptin

(2012) Yan-Ling He   CLINICAL PHARMACOKINETICS

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETOLOGIA

Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin

(2010) B. Ahrén et al.   DIABETES OBESITY & METABOLISM

Secondary Failure of Metformin Monotherapy in Clinical Practice

(2009) J. B. Brown et al.   DIABETES CARE

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy

(2008) D. M. Nathan et al.   DIABETOLOGIA

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE